These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9247853)

  • 21. Cerebral-cortex hexokinase. Elucidation of reaction mechanisms by substrate and dead-end inhibitor kinetic analysis.
    Bachelard HS; Clark AG; Thompson MF
    Biochem J; 1971 Aug; 123(5):707-15. PubMed ID: 5124380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allosteric regulation of glycogen synthase and hexokinase by glucosamine-6-phosphate during glucosamine-induced insulin resistance in skeletal muscle and heart.
    Virkamäki A; Yki-Järvinen H
    Diabetes; 1999 May; 48(5):1101-7. PubMed ID: 10331416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Controlling the growth rate of Saccharomyces cerevisiae cells using the glucose analogue D-glucosamine.
    McGoldrick EM; Wheals AE
    J Gen Microbiol; 1989 Sep; 135(9):2407-11. PubMed ID: 2697746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of chromium-adenosine triphosphate and lyxose to elucidate the kinetic mechanism and coordination state of the nucleotide substrate for yeast hexokinase.
    Danenberg KD; Cleland WW
    Biochemistry; 1975 Jan; 14(1):28-39. PubMed ID: 1089014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Binding of non-catalytic ATP to human hexokinase I highlights the structural components for enzyme-membrane association control.
    Rosano C; Sabini E; Rizzi M; Deriu D; Murshudov G; Bianchi M; Serafini G; Magnani M; Bolognesi M
    Structure; 1999 Nov; 7(11):1427-37. PubMed ID: 10574795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel approach for the development of selective Cdk4 inhibitors: library design based on locations of Cdk4 specific amino acid residues.
    Honma T; Yoshizumi T; Hashimoto N; Hayashi K; Kawanishi N; Fukasawa K; Takaki T; Ikeura C; Ikuta M; Suzuki-Takahashi I; Hayama T; Nishimura S; Morishima H
    J Med Chem; 2001 Dec; 44(26):4628-40. PubMed ID: 11741480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-acetyl-beta-D-glucopyranosylamine: a potent T-state inhibitor of glycogen phosphorylase. A comparison with alpha-D-glucose.
    Oikonomakos NG; Kontou M; Zographos SE; Watson KA; Johnson LN; Bichard CJ; Fleet GW; Acharya KR
    Protein Sci; 1995 Dec; 4(12):2469-77. PubMed ID: 8580837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Essential thiols of yeast hexokinase: alkylation by a substrate-like reagent.
    Otieno S; Bhargava AK; Barnard EA; Ramel AH
    Biochemistry; 1975 Jun; 14(11):2403-10. PubMed ID: 1095053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inactivation of yeast hexokinase by o-phthalaldehyde: evidence for the presence of a cysteine and a lysine at or near the active site.
    Puri RN; Bhatnagar D; Roskoski R
    Biochim Biophys Acta; 1988 Nov; 957(1):34-46. PubMed ID: 3140897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inactivation of yeast hexokinase by 2-aminothiophenol. Evidence for a 'half-of-the-sites' mechanism.
    Puri RN; Roskoski R
    Biochem J; 1988 Sep; 254(3):819-27. PubMed ID: 2848499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inactivation of yeast hexokinase by Cibacron Blue 3G-A: spectral, kinetic and structural investigations.
    Puri RN; Roskoski R
    Biochem J; 1994 May; 300 ( Pt 1)(Pt 1):91-7. PubMed ID: 8198558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cloning and biochemical characterisation of Aspergillus niger hexokinase--the enzyme is strongly inhibited by physiological concentrations of trehalose 6-phosphate.
    Panneman H; Ruijter GJ; van den Broeck HC; Visser J
    Eur J Biochem; 1998 Nov; 258(1):223-32. PubMed ID: 9851713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucosamine-6-phosphate synthase, a novel target for antifungal agents. Molecular modelling studies in drug design.
    Wojciechowski M; Milewski S; Mazerski J; Borowski E
    Acta Biochim Pol; 2005; 52(3):647-53. PubMed ID: 16082410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetic and crystallographic studies of glucopyranose spirohydantoin and glucopyranosylamine analogs inhibitors of glycogen phosphorylase.
    Watson KA; Chrysina ED; Tsitsanou KE; Zographos SE; Archontis G; Fleet GW; Oikonomakos NG
    Proteins; 2005 Dec; 61(4):966-83. PubMed ID: 16222658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Location in the yeast hexokinase structure of residues related to the enzyme activity.
    Gray AJ; Barron NM; Barnard EA
    Biosci Rep; 1983 Oct; 3(10):963-71. PubMed ID: 6360229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of fragment-based NMR screening, X-ray crystallography, structure-based design, and focused chemical library design to identify novel microM leads for the development of nM BACE-1 (beta-site APP cleaving enzyme 1) inhibitors.
    Wang YS; Strickland C; Voigt JH; Kennedy ME; Beyer BM; Senior MM; Smith EM; Nechuta TL; Madison VS; Czarniecki M; McKittrick BA; Stamford AW; Parker EM; Hunter JC; Greenlee WJ; Wyss DF
    J Med Chem; 2010 Feb; 53(3):942-50. PubMed ID: 20043700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinetic and proteomic analyses of S-nitrosoglutathione-treated hexokinase A: consequences for cancer energy metabolism.
    Miller S; Ross-Inta C; Giulivi C
    Amino Acids; 2007; 32(4):593-602. PubMed ID: 17051422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequencing a protein by x-ray crystallography. I. Interpretation of yeast hexokinase B at 2.5 A resolution by model building.
    Anderson CM; McDonald RC; Steitz TA
    J Mol Biol; 1978 Jul; 123(1):1-13. PubMed ID: 355642
    [No Abstract]   [Full Text] [Related]  

  • 39. Active site modulation in the N-acetylneuraminate lyase sub-family as revealed by the structure of the inhibitor-complexed Haemophilus influenzae enzyme.
    Barbosa JA; Smith BJ; DeGori R; Ooi HC; Marcuccio SM; Campi EM; Jackson WR; Brossmer R; Sommer M; Lawrence MC
    J Mol Biol; 2000 Oct; 303(3):405-21. PubMed ID: 11031117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanistic implications for Escherichia coli cofactor-dependent phosphoglycerate mutase based on the high-resolution crystal structure of a vanadate complex.
    Bond CS; White MF; Hunter WN
    J Mol Biol; 2002 Mar; 316(5):1071-81. PubMed ID: 11884145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.